Denali Therapeutics (DNLI) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
Denali Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 4 sold $1.3M of DNLI stock on the open market.
Get emailed when insiders cluster-buy stocks like DNLI
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
DNLI insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $435K | 5 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | — | 0 | $865K | 2 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 Denali Therapeutics Inc. insiders reported open-market purchases totaling $0, while 4 insiders reported sales totaling $1.3M. 3 of 7 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 9SEC | Peter Scott ChinChief Medical Officer | Sell | 1,654204,538 held (−1%) | $22.29 | $37K | -12.7% | — |
| Sep 4SEC | Nancy ThornberryDirector | Sell Plan | 10,82420,301 held (−35%) | $22.85 | $247K | -14.9% | — |
| Sep 4SEC | Nancy ThornberryDirector | Sell Plan | 61519,686 held (−3%) | $23.74 | $15K | -18.1% | — |
| Sep 3SEC | Alexander O. SchuthCofo And Secretary | Sell Plan | 2,768278,995 held (−1%) | $23.44 | $65K | -17.0% | — |
| Aug 13SEC | Alexander O. SchuthCofo And Secretary | Sell | 2,857281,763 held (−1%) | $25.07 | $72K | -22.4% | — |
| Jan 8SEC | Ryan J. WattsCEO, President | Sell | 35,198296,833 held (−11%) | $16.50 | $581K | +17.9% | — |
| Jan 8SEC | Alexander O. SchuthCofo And Secretary | Sell | 17,218282,828 held (−6%) | $16.50 | $284K | +17.9% | — |
Insiders at Denali Therapeutics Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Ryan J. WattsCEO, President | — | $581K | Jan 8, 2026 | — |
| Alexander O. SchuthCofo And Secretary | — | $421K | Sep 3, 2026 | — |
| Nancy ThornberryDirector | — | $262K | Sep 4, 2026 | — |
| Peter Scott ChinChief Medical Officer | — | $37K | Sep 9, 2026 | — |
DNLI stock: common questions
Are Denali Therapeutics Inc. insiders buying DNLI stock?
In the past 12 months, 0 insiders reported open-market purchases of DNLI worth $0.
Are Denali Therapeutics Inc. insiders selling DNLI stock?
4 insiders reported sales worth $1.3M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is DNLI's 52-week range?
Over the past year DNLI has traded between $14.41 and $27.21. It last closed at $19.45 on Oct 9, 2026.